Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #23770 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)
leifsmith
11/23/15 4:47 PM
#23771 RE: joball #23770
Rock Creek Pharmaceuticals Announces European Patent Allowance for the Administration of Anatabine to Treat Autism Spectrum and Seizure Disorders and Third Quarter Results SARASOTA, Fla., Nov. 9, 2015 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (OTCPK: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions, announced today its third quarter results. The Company also disclosed the Notification of Intent to Grant by the European Patent Office of a European patent for the administration of Anatabine to treat autism spectrum and seizure disorders.